Genfit Addresses Multiple Transition Issues With CEO Change

Co-founder and CEO Mouney will turn over the reins to former GSK and Lilly exec Pascal Prigent in mid-September.

Transition Vision Strategy Execution Speedometer Plan 3d Illustration - Illustration
Pascal Prigent will position Genfit for the commercial stage • Source: Shutterstock

As Genfit SA prepares to shift from a clinical- to a commercial-stage company, Pascal Prigent was named the firm's new CEO on 2 September because he brings the right skill set to make the transition.

Prigent was recruited for the French biotech in May 2018, as executive VP of marketing and commercial development. His prior...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Leadership

More from Scrip